PEAK1 and breast cancer: Moreover, Src- and Lyn induces the activation of Sgk269 (PEAK1), a cytoplasmic pseudokinase that is highly expressed in a basal subtype of BC and promotes EMT through both STAT3 and ERK activation [75,76].